Authors:
SACCO MG
GRIBALDO L
BARBIERI O
TURCHI G
ZUCCHI I
COLLOTTA A
BAGNASCO L
BARONE D
MONTAGNA C
VILLA A
MARAFANTE E
VEZZONI P
Citation: Mg. Sacco et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW MAMMARY ADENOCARCINOMA CELL-LINE DERIVED FROM MMTV NEU TRANSGENIC MICE, Breast cancer research and treatment, 47(2), 1998, pp. 171-180
Authors:
GIORELLO L
CLERICO L
PESCAROLO MP
VIKHANSKAYA F
SALMONA M
COLELLA G
BRUNO S
MANCUSO T
BAGNASCO L
RUSSO P
PARODI S
Citation: L. Giorello et al., INHIBITION OF CANCER CELL-GROWTH AND C-MYC TRANSCRIPTIONAL ACTIVITY BY A C-MYC HELIX L-TYPE PEPTIDE FUSED TO AN INTERNALIZATION SEQUENCE, Cancer research, 58(16), 1998, pp. 3654-3659
Authors:
SACCO MG
ZECCA L
BAGNASCO L
CHIESA G
PAROLINI C
BROMLEY P
CATO EM
RONCUCCI R
CLERICI LA
VEZZONI P
Citation: Mg. Sacco et al., A TRANSGENIC MOUSE MODEL FOR THE DETECTION OF CELLULAR STRESS-INDUCEDBY TOXIC INORGANIC-COMPOUNDS, Nature biotechnology, 15(13), 1997, pp. 1392-1397
Authors:
SACCO MG
BENEDETTI S
DUFLOTDANCER A
MESNIL M
BAGNASCO L
STRINA D
FASOLO V
VILLA A
MACCHI P
FARANDA S
VEZZONI P
FINOCCHIARO G
Citation: Mg. Sacco et al., PARTIAL REGRESSION, YET INCOMPLETE ERADICATION OF MAMMARY-TUMORS IN TRANSGENIC MICE BY RETROVIRALLY MEDIATED HSVTK TRANSFER IN-VIVO, Gene therapy, 3(12), 1996, pp. 1151-1156
Authors:
CORTI A
MERLI S
BAGNASCO L
DAMBROSIO F
MARINO M
CASSANI G
Citation: A. Corti et al., IDENTIFICATION OF 2 FORMS (31-33-KD AND 48-KD) OF THE URINARY SOLUBLEP55 TUMOR-NECROSIS-FACTOR RECEPTOR THAT ARE DIFFERENTIALLY N-GLYCOSYLATED AND O-GLYCOSYLATED, Journal of interferon & cytokine research, 15(2), 1995, pp. 143-152
Citation: A. Corti et al., IDENTIFICATION OF AN EPITOPE OF TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR-TYPE-1 (P55) RECOGNIZED BY A TNF-ALPHA-ANTAGONIST MONOCLONAL-ANTIBODY, Lymphokine and cytokine research, 13(3), 1994, pp. 183-190